Back to results
US 2020/0268019 A1Published application
Use of zinc and copper gluconate in the treatment of methicillin-resistant staphylococcus aureus
AssigneesDistributors Processing, Inc., Dantrace-Danfeed Ivs
InventorJens Jorgen Pedersen
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of zinc and copper gluconate in the treatment of methicillin-resistant Staphylococcus aureus and dietary supplements for mammals comprising zinc and copper gluconate and their use in treatment of methicillin-resistant Staphylococcus aureus.
Claims20
An animal feed comprising:
- zinc gluconate;
- and
- copper gluconate;
- wherein said zinc gluconate is present in the range of approximately 50 to 80 mg zinc/kg feed, and said copper gluconate is present in the range of approximately 5 to 25 mg copper/kg feed whereby said animal feed is effective as a treatment for methicillin-resistant Staphylococcus aureus.
1 more element
Dependencies are inferred from the claim text.